Paul Elliot Mann - Net Worth and Insider Trading

Paul Elliot Mann Net Worth

The estimated net worth of Paul Elliot Mann is at least $53 Million dollars as of 2025-07-02. Paul Elliot Mann is the CEO, 10% Owner of ASP Isotopes Inc and owns about 7,315,454 shares of ASP Isotopes Inc (ASPI) stock worth over $53 Million. Paul Elliot Mann is the CFO of Regenetp Inc and owns about 16,638 shares of Regenetp Inc (RGTPQ) stock worth over $2,596. Paul Elliot Mann is also the Director of Abeona Therapeutics Inc and owns about 0 shares of Abeona Therapeutics Inc (ABEO) stock worth over $0. Details can be seen in Paul Elliot Mann's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Paul Elliot Mann has not made any transactions after 2025-04-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Paul Elliot Mann

To

Paul Elliot Mann Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Paul Elliot Mann owns 4 companies in total, including Abeona Therapeutics Inc (ABEO) , Regenetp Inc (RGTPQ) , and Healthtech Solutions Inc (HLTT) among others .

Click here to see the complete history of Paul Elliot Mann’s form 4 insider trades.

Insider Ownership Summary of Paul Elliot Mann

Ticker Company Transaction Date Type of Owner
ABEO Abeona Therapeutics Inc 2021-02-19 director
RGTPQ Regenetp Inc 2020-03-31 Chief Financial Officer
HLTT Healthtech Solutions Inc 2021-07-13 director
LIMIT LIMIT 2025-04-17 director & 10 percent owner & Chief Executive Officer

Paul Elliot Mann Latest Holdings Summary

Paul Elliot Mann currently owns a total of 3 stocks. Among these stocks, Paul Elliot Mann owns 7,315,454 shares of ASP Isotopes Inc (ASPI) as of April 17, 2025, with a value of $53 Million and a weighting of 100%. Paul Elliot Mann owns 16,638 shares of Regenetp Inc (RGTPQ) as of March 31, 2020, with a value of $2,596 and a weighting of 0%. Paul Elliot Mann also owns 0 shares of Abeona Therapeutics Inc (ABEO) as of February 19, 2021, with a value of $0 and a weighting of 0%.

Latest Holdings of Paul Elliot Mann

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ASPI ASP Isotopes Inc 2025-04-17 7,315,454 7.19 52,598,114
RGTPQ Regenetp Inc 2020-03-31 16,638 0.16 2,596
ABEO Abeona Therapeutics Inc 2021-02-19 0 5.99 0

Holding Weightings of Paul Elliot Mann


Paul Elliot Mann Form 4 Trading Tracker

According to the SEC Form 4 filings, Paul Elliot Mann has made a total of 1 transactions in ASP Isotopes Inc (ASPI) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in ASP Isotopes Inc is the sale of 950,000 shares on April 17, 2025, which brought Paul Elliot Mann around $5 Million.

According to the SEC Form 4 filings, Paul Elliot Mann has made a total of 0 transactions in Regenetp Inc (RGTPQ) over the past 5 years. The most-recent trade in Regenetp Inc is the sale of 926 shares on March 31, 2020, which brought Paul Elliot Mann around $24,084.

According to the SEC Form 4 filings, Paul Elliot Mann has made a total of 6 transactions in Abeona Therapeutics Inc (ABEO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Abeona Therapeutics Inc is the sale of 1,823 shares on February 19, 2021, which brought Paul Elliot Mann around $108,447.

Insider Trading History of Paul Elliot Mann

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Paul Elliot Mann Trading Performance

GuruFocus tracks the stock performance after each of Paul Elliot Mann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Paul Elliot Mann is -26.94%. GuruFocus also compares Paul Elliot Mann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Paul Elliot Mann within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Paul Elliot Mann's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Paul Elliot Mann

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -15.44 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -16.01 LIMIT LIMIT LIMIT LIMIT LIMIT

Paul Elliot Mann Ownership Network

Ownership Network List of Paul Elliot Mann

No Data

Ownership Network Relation of Paul Elliot Mann

Insider Network Chart


Paul Elliot Mann Owned Company Details

What does Abeona Therapeutics Inc do?

Who are the key executives at Abeona Therapeutics Inc?

Paul Elliot Mann is the director of Abeona Therapeutics Inc. Other key executives at Abeona Therapeutics Inc include SVP & General Counsel Brendan M. O'malley , director & Chief Executive Officer Vishwas Seshadri , and Chief Financial Officer Joseph Walter Vazzano .

Abeona Therapeutics Inc (ABEO) Insider Trades Summary

Over the past 18 months, Paul Elliot Mann made no insider transaction in Abeona Therapeutics Inc (ABEO). Other recent insider transactions involving Abeona Therapeutics Inc (ABEO) include a net sale of 50,974 shares made by Mark Alvino , a net sale of 45,676 shares made by Vishwas Seshadri , and a net sale of 12,187 shares made by Joseph Walter Vazzano .

In summary, during the past 3 months, insiders sold 88,941 shares of Abeona Therapeutics Inc (ABEO) in total and bought 0 shares, with a net sale of 88,941 shares. During the past 18 months, 180,736 shares of Abeona Therapeutics Inc (ABEO) were sold and 62,758 shares were bought by its insiders, resulting in a net sale of 117,978 shares.

Abeona Therapeutics Inc (ABEO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Abeona Therapeutics Inc Insider Transactions

No Available Data

Paul Elliot Mann Mailing Address

Above is the net worth, insider trading, and ownership report for Paul Elliot Mann. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Paul Elliot Mann's mailing address is: Boca Raton Fl 33432.